Background: Cyclin-dependent kinase (CDK) 4/6 inhibitor-based therapies have shown
great promise in improving clinical outcomes for patients with hormone receptor-positive …

Data on paediatric pulmonary embolism (PE) are scarce. We sought to systematically review
the current literature on childhood PE and conducted a search on paediatric PE via PubMed …

Objective—Pulmonary embolism (PE) is a life-threatening manifestation of venous
thromboembolism with a high recurrence rate after anticoagulation cessation. Recently, we …

Acute pulmonary embolism (PE) is a significant cause of mortality and morbidity across the
globe. Over the last few decades, there have been major therapeutic advances in acute PE …

Early effective identification of high-risk patients for acute pulmonary embolism (APE)
contributes to timely treatment. The pulmonary artery obstruction index (PAOI) in computed …

Background: Mechanical thrombectomy plays an important role in the management of acute
pulmonary embolism (PE), either when rapid clot dissolution is needed or when …

Purpose Recurrence is a major clinical problem in patients with pulmonary embolism and
can affect mortality. The decision to discontinue treatment is important for recurrence and is …

Pulmonary embolisms (PEs) are obstructions of the pulmonary arteries by thrombi, which
are emboli and they most frequently originate from the deep venous system of the inferior …

Venous thromboembolism (VTE) occurs frequently and represents a serious threat to patient
health. However, its effects on mental health have not been studied sufficiently. The …

Context: Statins have been widely used in acute pulmonary embolism (APE), while
simvastatin has been well-established for the prevention of pulmonary hypertension, which …